The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Robert L. Frye, Malcolm R. Bell, Hartzell V Schaff, Richard Holubkov, Katherine M. Detre

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

Original languageEnglish (US)
Pages (from-to)16-20
Number of pages5
JournalCurrent Diabetes Reports
Volume2
Issue number1
StatePublished - Feb 2002

Fingerprint

Percutaneous Coronary Intervention
Coronary Artery Bypass
Coronary Artery Disease
Diabetes Mellitus
Practice Guidelines
Type 2 Diabetes Mellitus
Observational Studies
Cause of Death
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

The role of PCI and CABG in the management of coronary artery disease in patients with diabetes. / Frye, Robert L.; Bell, Malcolm R.; Schaff, Hartzell V; Holubkov, Richard; Detre, Katherine M.

In: Current Diabetes Reports, Vol. 2, No. 1, 02.2002, p. 16-20.

Research output: Contribution to journalArticle

Frye, Robert L. ; Bell, Malcolm R. ; Schaff, Hartzell V ; Holubkov, Richard ; Detre, Katherine M. / The role of PCI and CABG in the management of coronary artery disease in patients with diabetes. In: Current Diabetes Reports. 2002 ; Vol. 2, No. 1. pp. 16-20.
@article{a37e4b74d22a420e885f5626fb2d6fdb,
title = "The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.",
abstract = "The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.",
author = "Frye, {Robert L.} and Bell, {Malcolm R.} and Schaff, {Hartzell V} and Richard Holubkov and Detre, {Katherine M.}",
year = "2002",
month = "2",
language = "English (US)",
volume = "2",
pages = "16--20",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

AU - Frye, Robert L.

AU - Bell, Malcolm R.

AU - Schaff, Hartzell V

AU - Holubkov, Richard

AU - Detre, Katherine M.

PY - 2002/2

Y1 - 2002/2

N2 - The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

AB - The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

UR - http://www.scopus.com/inward/record.url?scp=3142748908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142748908&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 16

EP - 20

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 1

ER -